The Spring session of CMEpalooza featured two full days of live programming designed for the continuing medical education community. This year, PlatformQ Health (PQH) sent two delegates to the session titled Including Patients and Patient Advocacy Groups in Educational Planning & Delivery: How to Make It a “Win-Win”. Senior VP of Education, Kathryn Pucci, acted […]
February is shaping up to be a busy time on the PlatformQ Health network. This month’s live broadcasts include a panel discussion on the new Heart Failure Guidelines and information about the latest treatment strategies for schizophrenia, as well as programs with Association of Community Cancer Centers (ACCC) and Depression and Bipolar Support Alliance (DBSA) […]
Schizophrenia is a mental health disorder that is chronic and disabling and affects the way a person thinks, feels, and behaves. Typically, symptoms start between the ages of 16 and 30; rarely it is observed in children as well. Symptoms of this disease are categorized into 3 types – positive, negative, and cognitive: Positive symptoms: These […]
PlatformQ Health Education, in joint providership with the American Academy of Family Physicians (AAFP), announces the first of two online educational programs on shared decision making in major depressive disorder (MDD) treatment. Major depressive disorder (MDD) has substantial negative effects on patients’ functional abilities and quality of life. This tethered, or mutual, education will focus […]
Healthcare professionals and policymakers are struggling to come to terms with the epidemic of opioid abuse and overdose in the United States – perhaps nowhere more than here in Massachusetts, where the presence of premier medical institutions has not been able to stem the state’s record high rates of opioid-overdose deaths (which are among the […]